Compare Humana Inc (HUM) vs Texas Instruments Incorporated (TXN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Texas Instruments Incorporated — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while Texas Instruments Incorporated trades at $281.58 (market cap $256.11B). The key difference: Texas Instruments Incorporated is far larger — about 5.5× Humana Inc's market cap, and Texas Instruments Incorporated pays the higher dividend (2.03%). Which is the better fit depends on your goals.
| HUM | TXN | |
|---|---|---|
Market Cap | $46.31B | $256.11B |
Sector | Health | Technology |
52-Week High | $409.42 | $332.35 |
52-Week Low | $163.67 | $153.33 |
Enterprise Value | $53.67B | $263.16B |
Dividend Yield | 0.92% | 2.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Texas Instruments (TXN) trades at $286.08, up 2.76% in the last 24 hours, with a bullish technical signal and strong earnings beats in recent quarters. The company shows robust profitability with a 31.11% net income margin and 34.97% ROE, though valuation ratios like P/E of 43.48 are elevated. Recent news highlights CFO transition and AI-driven demand growth, supporting positive sentiment.
Outlook remains favorable with a consensus price target of $333.10, but risks include high debt-to-asset ratio of 40.61% and competitive pressures. Investment opportunity lies in operational leverage from 300mm capacity expansion, while macroeconomic volatility and execution risks warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Read more on TXN →
